2016
DOI: 10.1373/clinchem.2015.242495
|View full text |Cite
|
Sign up to set email alerts
|

An Empirical Approach to Signature Peptide Choice for Selected Reaction Monitoring: Quantification of Uromodulin in Urine

Abstract: BACKGROUND: Many avenues have been proposed for a seamless transition between biomarker discovery data and selected reaction monitoring (SRM) assays for biomarker validation. Unfortunately, studies with the abundant urinary protein uromodulin have shown that these methods do not converge on a consistent set of surrogate peptides for targeted mass spectrometry. As an alternative, we present an empirical peptide selection work flow for robust protein quantification.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
27
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(30 citation statements)
references
References 27 publications
3
27
0
Order By: Relevance
“…Differential interindividual variability of proteins was observed, indicating unique regulation (e.g., mediated by individual genetic and epigenetic factors) of these proteins. The highest variability was observed for Tamm-Horsfall protein, consistent with reported values (Fu et al, 2016). However, as the main aim of this report was methodological, unique interindividual variability has no effect on our conclusions.…”
Section: Discussionsupporting
confidence: 90%
“…Differential interindividual variability of proteins was observed, indicating unique regulation (e.g., mediated by individual genetic and epigenetic factors) of these proteins. The highest variability was observed for Tamm-Horsfall protein, consistent with reported values (Fu et al, 2016). However, as the main aim of this report was methodological, unique interindividual variability has no effect on our conclusions.…”
Section: Discussionsupporting
confidence: 90%
“…Following identification of potential proteomic biomarkers using top-down/bottom-up mass spectrometry, validation and absolute quantification of urine biomarkers is best achieved by Selected Reaction Monitoring (SRM) [35, 78, 79]. SRM, also known as Multiple Reaction Monitoring (MRM), allows previously defined peptides and fragment ions, known as signature peptides, to be quantified by monitoring multiple fragment ions produced during collision-induced dissociation [18].…”
Section: Advancements In Mass Spectrometry Based Urinary Proteomicsmentioning
confidence: 99%
“…SRM, also known as Multiple Reaction Monitoring (MRM), allows previously defined peptides and fragment ions, known as signature peptides, to be quantified by monitoring multiple fragment ions produced during collision-induced dissociation [18]. For robust SRM analysis with strong signal intensity, the peptides for SRM analysis must be unique to the protein of interest, should not contain post-translational modifications, and should not have genetically encoded variations [78]. Absolute quantification can be performed with stable isotope-labeled peptides corresponding to the signature peptides.…”
Section: Advancements In Mass Spectrometry Based Urinary Proteomicsmentioning
confidence: 99%
See 1 more Smart Citation
“…These include the proper collection, processing and storage of specimens from large cohorts for proteomic analysis, development of standard operating procedures for multiple reaction monitoring, external quality control for assays including blind duplicates, and proficiency samples from quality control pools [17]. Substantial progress has been made in developing multiple reaction monitoring assays in urine, particularly of the candidate CKD biomarker uromodulin [22,23]. While CKD BioCon has not produced any breakthrough CKD biomarkers to date, it clearly has set standards for programmatic efforts to identify renal disease biomarkers and raised standards to those used in successful cancer biomarker consortiums.…”
Section: Difficult Lessons Learnedmentioning
confidence: 99%